Evaluation of the Karman Line Memory Strategy Training — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of the Karman Line Memory Strategy Training — Stella

Recruiting

Back to Acquired Brain Injury (Including Stroke) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Netherlands

Klimmendaal Revalidatiespecialisten, Arnhem, Gelderland

Key details

Sponsor

Klimmendaal Revalidatiespecialisten

Enrollment target

~6 participants

Started

January 2025

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov